Back to search
FDAFDA · Food and drugs·Recall number Z-1240-2025

Brivo MR355, NMRI system

Published March 5, 2025 · Recall initiated: January 31, 2025

Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

For certain MR systems, a scan can be resumed following a Power Monitor trip when the "6-minute average SAR" is above the limit indicated on the "SAR Display". The user interface may incorrectly enable a scan to proceed earlier than intended. If resumed by the operator, such a scan can result in potential excessive tissue heating, especially if the patient is in contact with a conductive material or has an implant.

What to do

Voluntary: Firm initiated · Letter

Recall details

Manufacturer
GE Healthcare (China) Co., Ltd.
Distributor
Domestic US distribution nationwide. International distribution worldwide.
Lot
Brivo MR355 (No UDI) System IDs 082427010096 082427020046 082427040126 082427070076 082427070077 082427070170 082427100245 082427120151 082427180030 082427210147 082427210148 082427220025 082427220045 082427230060 082427240060 082427310104 0856270058 0856270059 MRR10200 MRR9920 RU1063MR03 RU8902MR01 (Updated 12/29/25 - Additional System ID 83027805544513) (Updated 1/28/26 - Additional System IDs: 82427220047 82427240055 82427070163 82427060068 82427140137 82427010122 82427280018) (Updated 2/19/26: Additional System ID EG1736MR02)
Risk classification
Class II
Area (FDA)
device
Country
China

Sell products like this?

Recalert watches your whole catalog for recalls like this one, automatically.

Start free — no card